{"name":"Oruka Therapeutics, Inc.","slug":"oruka-therapeutics-inc","ticker":"","exchange":"","domain":"oruka.com","description":"","hq":"","founded":0,"employees":"","ceo":"","sector":"Pharma / Biotech","stockPrice":0,"stockChange":0,"stockChangePercent":0,"marketCap":"","metrics":{"revenue":0,"revenueGrowth":0,"grossMargin":0,"rdSpend":100640000,"netIncome":-105433000,"cash":46935000,"dividendYield":0,"peRatio":0,"fiscalYear":"FY2023"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"}],"diseaseAreas":[],"pipeline":[],"recentEvents":[],"realNews":[{"url":"https://news.google.com/rss/articles/CBMixAFBVV95cUxOWWFfWk1FUTBDbG1IREdQelZDQjNUejdhX1cwcVN4cUY1YTFIbnk1dFdtWTd5LW5aYmlBalRqa2lLeTBqdmZIRU4wS2ppLTRuWDZ0X09lanNxTmM4bGFUY2drMV9XaVltZUxGQlc0UkMxSzJTMlEzUWxKN2lYc0FVeHRXN0k1RXZBc2xPeXhoU0lRWkJXVUZNTnZBZVE4My14ZGExcjBlR2x1MzRIZ1FoNEhQS2Jia0l0MzdIcHREajEtQWY3?oc=5","date":"2026-03-29","type":"pipeline","source":"National Today","summary":"Oruka Therapeutics and Clearmind Medicine Vie for Investor Dollars - National Today","headline":"Oruka Therapeutics and Clearmind Medicine Vie for Investor Dollars","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMitwFBVV95cUxNdXpDTEswZ3ZKZWhrbkRJX2lwRXItSDNhUzBKVWhjS0NJSV9oT1dVRnlXZGJ4WVVWVklwMWpiYU9YaTJFcy1iNHRZbzBRS09tbXlla19Ndl9lWEhkci1ScUhaNFE1ZkJlNkctNVE5bm1Kb2lNTWU1alNFWGhLZkpQSkFDTmFMdWJKaUR0OW1iVkd1V3ZmZzVtRF81akhhM3ZLMnlCdkV5WWZ3VEJtMzloM0FIRldGQ2M?oc=5","date":"2026-03-17","type":"pipeline","source":"Stock Titan","summary":"[Form 4] Oruka Therapeutics, Inc. Insider Trading Activity - Stock Titan","headline":"[Form 4] Oruka Therapeutics, Inc. Insider Trading Activity","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiqgFBVV95cUxPYUM3SDdEZHdFcHV1Y0pVckI2Y0RrVERCYVhEUS1lWUhNdUVObDY0VTFZbjEwM2R4dkt1a3hsTG50ck9ObnlMQXB5M2lkMm1yQ0pTSS12cnVWeG51V0tKU1JLbko2aXZ3M25UOFJGTkxUUWZ0RG0zb19hYmM1NHFucUZueE1POXJtb3QxSlczZmZzWC1LdDcyUHU2S3IyU29VSnJDWW9OZjJPdw?oc=5","date":"2026-03-12","type":"pipeline","source":"Medscape","summary":"Tachyphylaxis in Psoriasis: What’s Really Happening? - Medscape","headline":"Tachyphylaxis in Psoriasis: What’s Really Happening?","sentiment":"neutral"},{"date":"2026-03-12","type":"earnings","source":"SEC EDGAR","summary":"10-K filed with SEC: ANNUAL REPORT","headline":"Annual Report (10-K) Filed","sentiment":"neutral"},{"url":"https://news.google.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?oc=5","date":"2026-03-11","type":"trial","source":"simplywall.st","summary":"Assessing Oruka Therapeutics (ORKA) Valuation As ORKA-001 Moves Into Long Term Psoriasis Trial - simplywall.st","headline":"Assessing Oruka Therapeutics (ORKA) Valuation As ORKA-001 Moves Into Long Term Psoriasis Trial","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMi1AFBVV95cUxOS01VZFp1Nllyb1BoTWFaWklPem5SUDVlRUJQOG1UQUk4MEw2R3NLWF80UnNvTFV6b3RJck1kNmI1cTRELTFmUE9JbG1DS1VsemhmVHAzc3JRak15aEh4VDVtVHNONVZsZlRYUTNCc3h3cXA3enQzSktwSjZPX1R3cXN1R1pWZVQzbkJ0OTJSUFdWZHhGVzNDcTVULWE5UmJqTnBCajk0V3ZjMmJPREpNV243MURqSzZXT3pxRzdKSHVfMDZaLTMtWFItZGJJcFNXaEM3UA?oc=5","date":"2026-02-09","type":"pipeline","source":"GlobeNewswire","summary":"Oruka Therapeutics to Participate in Multiple Upcoming Conferences - GlobeNewswire","headline":"Oruka Therapeutics to Participate in Multiple Upcoming Conferences","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMirAFBVV95cUxQRFJHM0JPd2NWRWkxLWJKR3hYckVFRThqS1VBeDNHdUlrY296aHYtWFFyQUQwZjF1bDFwVkh2NU5SUU9WcnJxOTRSTzdhU053N2RwS2RxUERoS2c5WXJHcnFITFN3dzlwSlJoMW9CODZLQmRBTDk4bWNSVmVnV2pyNVNrYm5oYm5CWmc5bDFWekttVzdKR01BZ1lDQkpUUm1hZUVzLUo0UVN1R1BQ?oc=5","date":"2025-12-01","type":"earnings","source":"Voronoi by Visual Capitalist","summary":"Andreas Halvorsen’s Q3 2025 Portfolio — Viking’s Strategic Allocation - Voronoi by Visual Capitalist","headline":"Andreas Halvorsen’s Q3 2025 Portfolio — Viking’s Strategic Allocation","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiXEFVX3lxTE85WlRMUTRucjNMTUtNM0FKb3pfamtiZVFaeFMwdDlnRkhucXJiblg2QTdmQVBDa0dPVTV4cWNXVi1aNGk4d0Fxa3JzNjdmdjI2eTEtay1LcXJDaUs4?oc=5","date":"2025-11-10","type":"pipeline","source":"TradingView","summary":"ORKA Stock Price and Chart — NASDAQ:ORKA - TradingView","headline":"ORKA Stock Price and Chart — NASDAQ:ORKA","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMigwFBVV95cUxPTVFUMXF5cnRIQlFRMlFvYUpEZGNmS3ZaUmI4Nno5cDBCbnlmVjY2clhRRmtaZ29McW4xcVdTQWFPQjg0T0tEUU0wQkQ3bEhuVkwwOGk0eUd3aVpSZU5peThzSElWQktQLWRRNnJIZ0E5R0g1TDJoQ25WQldXeXAyd2JpMA?oc=5","date":"2025-09-17","type":"pipeline","source":"statnews.com","summary":"Oruka Therapeutics brings back the ‘wall-crossed’ PIPE - statnews.com","headline":"Oruka Therapeutics brings back the ‘wall-crossed’ PIPE","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMickFVX3lxTFAzRHZyUmJaNmNoUTdkMGNya25aRkd1VXVCaW1KR1lYdmY5WWVWVzNvb3RRVjZnNnlqZ05ISkxCOVFQYWRmMWpwTWpjZXlWeE1NOGVObTV0QTdrSkwyU3o1VDBwLWIxeVI5R2VvTTEtcFNRdw?oc=5","date":"2024-07-01","type":"pipeline","source":"The Pharma Letter","summary":"Oruka Therapeutics - The Pharma Letter","headline":"Oruka Therapeutics","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMi1AFBVV95cUxQakFFMW9BSlh4bm4tUWJsNG4zQTRlNWRWRHRCb0RsMWRYY244RVBlNzFLVGE4UE5oREtibEp2SzZIb0NrVXJqV1RHLXNsSHVydzJVOUxxVEMzMXBJNFNrOUEyaWtJUGZnZ0w2V2RJZElLcHRTd3lreFZHNU9CVDN1MmJkal8tUGo3UlZMd1EydGhhalU2R2dYX3JwTWo2UXVxRmhYQTh0T2JKRzZZOGZTY1NWNGFMaXpjcnRLblBHTDBWV1pwUDJjRDk5MFl3emZ3RWpnNA?oc=5","date":"2024-04-15","type":"pipeline","source":"Genetic Engineering and Biotechnology News","summary":"Skin in the Game: Oruka Takes on Blockbuster Drugs for Psoriasis, Dermatological Disorders - Genetic Engineering and Biotechnology News","headline":"Skin in the Game: Oruka Takes on Blockbuster Drugs for Psoriasis, Dermatological Disorders","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiuAJBVV95cUxOaHVDanpvTlpHU3ExNTlOSmx0Y25tWVJjQThGbzBPNnhUM0RGSFpaaGZfb0pIeWF6bWc0QnBLT1Rjb2RseDdzTVBjcUVXMjNUQmxwTWZhSDVmaEJsdWNKeE1FaFV4aVJ6b2k4aWczT1JtNTJLWmhzeG12azJrcFliblFHZHFDZjBLZ0RjTlZmOWxXWUc1TXk0bTFzVS05Q3VrU2xVb3pzUXBLMFB1a2RrZ1lULTJmdVM3NzRQdFo3VkZ2WVV3emJYRGVKTXBxbkFBTlJVbTRxblExZ3ZRMEhUeHFRcG1wcndlX3FKWWJ4NEs0NVlvZnoxMWNUYmhMUzJVZ3EwUzZnOHdsZnVRNW1TYlJIUW94REpvSXZCMHR0NFlVR3VGRHlNWXlUM0xzSTBOZnUxTXF5MUc?oc=5","date":"2024-04-03","type":"deal","source":"PR Newswire","summary":"Paragon Therapeutics Announces Oruka Therapeutics Has Entered into Merger Agreement with ARCA biopharma to Advance Novel Treatments for Chronic Skin Diseases - PR Newswire","headline":"Paragon Therapeutics Announces Oruka Therapeutics Has Entered into Merger Agreement with ARCA biopharma to Advance Novel","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMinwFBVV95cUxPTDlHYThiS0wwdTQtYXJzdEI2UWdibGpzOVFNbEFmV2liNjkwTDk1TDg0UXVyVmxsQlp2VHNtb3hFbFRBUU4tTlB6SWFaUkc2VTdQUk1YekFxNFk1X2wxS2Q2T0pqYm42dTFpbVFMMEVtNkp4SHl4aEExNkxkczRMMlhjS2hyY3h1SWhqTDNaNjZqTDlqUEd3LVk5cThTZGs?oc=5","date":"2024-04-03","type":"deal","source":"Fierce Biotech","summary":"Oruka spins out of Paragon with 3 assets, reverse merger and cash - Fierce Biotech","headline":"Oruka spins out of Paragon with 3 assets, reverse merger and cash","sentiment":"neutral"}],"patents":[],"drugCount":0,"phaseCounts":{},"enrichmentLevel":3,"visitCount":1,"keyCompetitors":[],"therapeuticFocus":[],"financials":{"source":"sec_edgar+yahoo","revenue":0,"revenuePeriod":"2023-12-31","revenueHistory":[{"value":0,"period":"2023-12-31"},{"value":0,"period":"2022-12-31"},{"value":0,"period":"2021-12-31"},{"value":0,"period":"2020-12-31"},{"value":0,"period":"2019-12-31"},{"value":0,"period":"2018-12-31"}],"grossProfit":null,"grossProfitHistory":[],"rdSpend":100640000,"rdSpendHistory":[],"sgaSpend":null,"operatingIncome":null,"operatingIncomeHistory":[],"netIncome":-105433000,"netIncomeHistory":[],"eps":null,"epsHistory":[],"cash":46935000,"cashHistory":[],"totalAssets":488617000,"totalLiabilities":null,"totalDebt":null,"equity":null,"operatingCashflow":null,"operatingCashflowHistory":[],"capex":null,"capexHistory":[],"freeCashflow":null,"dividendsPaid":null,"buybacks":null,"employees":null,"segmentRevenue":[],"geographicRevenue":[],"quarterly":{"income":[]},"ciks":null,"lastFiledAt":null},"yahoo":null}